Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Cannabis

A significant number of cannabis patients discontinue use of benzodiazepines

by Eric W. Dolan
May 8, 2019
in Cannabis, Psychopharmacology
(Photo credit: William Casey)

(Photo credit: William Casey)

Share on TwitterShare on Facebook
Stay on top of the latest psychology findings: Subscribe now!

A new study has found that many patients stop using benzodiazepine after receiving medical cannabis. The findings have been published in the journal Cannabis and Cannabinoid Research.

“I was interested in this project because it presented an opportunity to address benzodiazepines and cannabis use, both of which are becoming increasingly socially relevant. Benzodiazepines can be effective in treating many medical conditions but unlike opioids, there seems to be little public awareness of the risks associated with these commonly used prescription medications,” said study author Chad Purcell, a medical student at Dalhousie University.

Benzodiazepines are a class of medications used to treat conditions such as anxiety and insomnia. They include Alprazolam (Xanax, Niravam) diazepam (Valium), clonazepam (Klonopin), lorazepam (Ativan) and others.

“Having previously worked as a pharmacist, I observed first-hand how benzodiazepines affected the lives of my patients. I became familiar with the adverse effects of these medications that include dependency, falls and increased sedation — especially when used in combination with other medications,” Purcell explained.

“I was excited to investigate the potential mitigation of these risks. With the legalization of cannabis in Canada, Canadian researchers are uniquely positioned to contribute to the developing body literature on the drug. I wanted to take this opportunity to help further understand of the potential uses and harms of cannabis.”

The researchers observed significant benzodiazepine discontinuation rates in 146 medical cannabis patients, who were all regularly consuming benzodiazepines at the beginning of the study. Approximately 45 percent of patients had stopped taking benzodiazepine medication within about six months of beginning medical cannabis.

Many patients also reported decreased daily distress due to medical conditions after being prescribed cannabis.

“We observed a significant number of patients who stopped taking their benzodiazepine medications once started on medical cannabis. We hope that future research will explain this observation and provide recommendations for patients who use benzodiazepines and/or cannabis,” Purcell told PsyPost.

But there are still many unanswered questions about the relationship between cannabis use and benzodiazepine discontinuation.

“The study design precludes our ability to reliably state that the discontinuation of benzodiazepines was caused by initiating medical cannabis. We can simply state that this association was observed. We are also not able to suggest a possible physiological mechanism to explain this association,” Purcell said.

“We did not have access to information on cannabis strains, growth and producers and are unable to generalize these results to products that are currently commercially available in Canada. We do not suggest that cannabis can or should be used as a substitute or addition to medically indicated and prescribed benzodiazepines.”

The study, “Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis“, was authored by Chad Purcell, Andrew Davis, Nico Moolman, and S. Mark Taylor.

TweetSendScanShareSendPin3ShareShareShareShareShare

RELATED

Pills spilling out of a bottle on a table
ADHD

Methylphenidate: ADHD drug curbs impulsivity in men only, linked to brain wiring differences

July 13, 2025

Researchers found that methylphenidate lowers impulsive choice behavior in men but not women. The effect was associated with the structural integrity of specific white matter tracts in the brain, highlighting potential sex-based differences in drug response.

Read moreDetails
Researchers identify 45 distinct brain connectivity alterations linked to anorexia nervosa
MDMA

Brain scans reveal who may benefit most from MDMA for trauma-related symptoms

July 13, 2025

MDMA-assisted therapy shows promise for trauma, but its effects vary. Now, a study in JAMA Network Open offers a solution: brain scans that measure reactivity to unconscious threat cues can identify individuals most likely to respond positively to the treatment.

Read moreDetails
A surprising body part might provide key insights into schizophrenia risk
Addiction

Neuroscientists shed new light on how heroin disrupts prefrontal brain function

July 11, 2025

After heroin exposure and abstinence, mice showed reduced prefrontal brain activity during social interaction but heightened responses to drug-related cues, suggesting heroin disrupts normal brain function in ways that may contribute to social withdrawal and relapse risk.

Read moreDetails
Loss of empathy in frontotemporal dementia traced to weakened brain signals
ADHD

Adults treated with psychostimulants for ADHD show increased brain surface complexity, study finds

July 10, 2025

Researchers have discovered that long-term psychostimulant use in adults with ADHD is associated with increased brain surface complexity, yet these anatomical differences appear unrelated to clinical outcomes, according to a study using high-resolution MRI data from UCLA.

Read moreDetails
Little-known psychedelic found to have a fascinating effect on cognitive flexibility after just a single dose
Psychedelic Drugs

Fascinating new advances in psychedelic science reveal how they may heal the mind

July 9, 2025

A series of recent studies has begun to map the specific neural, cognitive, and emotional processes that psychedelics influence—often in ways that challenge long-held assumptions

Read moreDetails
Ketamine repairs reward circuitry to reverse stress-induced anhedonia
Depression

Ketamine repairs reward circuitry to reverse stress-induced anhedonia

July 9, 2025

New research shows a single low, non-anesthetic dose of ketamine revived pleasure seeking in chronically stressed mice by restoring weakened excitatory synapses onto nucleus accumbens dopamine D1 neurons, pinpointing a circuit mechanism for the drug’s rapid antidepressant effect.

Read moreDetails
Use of mescaline may facilitate unintended improvements in several psychiatric conditions, study suggests
Ayahuasca

Many ayahuasca users report challenging experiences—yet some are linked to better mental health

July 4, 2025

Are challenging ayahuasca experiences always harmful? Not necessarily, finds a new global survey. While some effects predict poorer mental health, others like visual distortions are linked to positive outcomes, highlighting the crucial role of context and individual vulnerability.

Read moreDetails
Taking medicinal cannabis oil for insomnia does not impair cognition on the following day
Cannabis

Cannabis oil might help with drug-resistant epilepsy, study suggests

July 2, 2025

Nineteen patients with drug-resistant epilepsy experienced seizure freedom after cannabis oil treatment, with a median seizure-free duration of 245 days. Five remained seizure-free for over a year, and most reported improved quality of life and reduced seizure frequency.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

The triglyceride-glucose index: Can it predict depression risk in the elderly?

People with ADHD exhibit altered brain activity before making high-stakes choices

Narcissistic individuals are more prone to maladaptive daydreaming

Effort or fate? Sexual mindsets predict whether bedroom bliss spills over into broader wellbeing

People who use AI may pay a social price, according to new psychology research

Researchers identify a shared brain pattern behind feeling surprised

New research shows the psychological toll of the 2024 presidential election

Methylphenidate: ADHD drug curbs impulsivity in men only, linked to brain wiring differences

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy